). Mutations determining mitomycin resistance in Bacillus subtilis. J. Bacteriol. 92:1663Bacteriol. 92: -1669Bacteriol. 92: . 1966.-The pattern of development of genetic resistance in Bacillus subtilis to mitomycin C was studied, and spontaneous single and multistep mutants were obtained. The transmission and expression of these mutations in sensitive strains proved possible by means of genetic transformation. The mutations were genetically studied in relation to a chromosomal mutation, mac-1, which confers resistance to the macrolide antibiotic erythromycin and which has been previously localized in the early-replicating segment of the B. subtilis chromosome. The results indicate that all of three primary mutations studied in this manner, as well as a secondary and tertiary mutation derived from one of the primary mutations, are clustered in this early-replicating segment. It appears that the secondary and tertiary mutations enhance the resistance conferred by the primary mutation, apparently without themselves conferring any resistance.
The mitomycins are a group of alkylating antibiotics that are structurally well characterized and that have a useful degree of molecular specificity (21) . Mutants with altered resistance to these antibiotics display at least two interesting properties. Resistant Escherichia coli mutants have been reported to be cross-resistant to a number of diverse and structurally dissimilar agents (9, 12, 25) , and hypersensitive mutants of both E. coli and Bacillus subtilis have been shown to be deficient in a recombination function (2, 14, 27) . In studying the genetic basis of these properties, a system in which mitomycin-resistance mutations are transferable could be potentially useful. This paper reports the pattern of development of resistance to mitomycin C by B. nutrient agar (NA) containing mitomycin C (MC), or from mutational and recombinational derivatives of it; the mutation was then introduced by genetic transformation into strain 168. The frequency of spontaneous mutants on NA supplemented with 0.14 ,ug/ml of MC was 10-7 to 10". The origin and derivation of mutations characterized in the present study are indicated in Table 1 .
Determination of resistance. MC was purchased from the Kyowa Hakko Co., Japan (lot 5 M-1). Erythromycin was purchased from Abbott Laboratories Ltd. Aqueous solutions of the antibiotics were prepared at a concentration of 100 ,ug/ml and frozen until used. Cells were grown to the exponential phase in Difco Penassay Broth, and their resistance was determined by spreading them in various concentrations on the surface of NA supplemented with increasing amounts of the antibiotic. When resistance was determined by velvet replication, the transformants selected from NA plus 0.15 ,g/ml of MC were transferred to and allowed to grow on antibiotic-free NA before replicating on NA supplemented with different antibiotics or different concentrations of the same antibiotic.
Transformation procedures. Transforming deoxyribonucleic acid (DNA) was extracted and purified by the procedure described by Marmur (13) 
RESULTS
Pattern of development of resistance. Twenty stable single-step spontaneous mutants from independent cultures were initially isolated on NA containing 0.14 ,ug/ml of MC. The resistance of these strains after at least two cycles of growth in antibiotic-free media was within the narrow range of 1.3 to 4.0 times that of the parent. Three of these single-step mutants were used for genetic studies.
Second-and third-step resistant mutants were isolated successively from one of the first-step mutants, mit-2. These mutants were designated respectively mit-2-01 and mit-2-01-001. Figure 1 illustrates the resistance of the single-step and multistep resistant mutants. Single-step mutants with a level of resistance higher than those reported here have not so far been encountered. In E. coli strain S, Greenberg et al. (9) found that the resistance of first-step mutants varied in the much broader range of 1.4 to 31 times that of the parent strain. From one of the first-step mutants 9 times more resistant than the parent strain, they isolated, in five consecutive steps, a strain 325 times more resistant than the parent strain. Genetic analyses in both systems can unequivocally establish whether the differences observed between the two systems are qualitative. This possibility was explored in B. subtilis, with DNA-mediated transformation as the means for disseminating and recombining the mutations.
Genetic transfer and expression of resistance. A competent culture of strain 168 trp-2 was exposed at 37 C to transforming DNA extracted from a strain bearing the markers mit-2 and mac-i (conferring resistance to erythromycin and other macrolide antibiotics), as well as trp-2. The exposure was terminated with deoxyribonuclease after 10 min; the culture was then diluted 20-fold with fresh medium and allowed to grow further with shaking at 37 C. At various intervals during growth, the culture was examined for total viable cells on NA and for the three classes of transformants on minimal agar (1) and on NA supplemented with 0.15 ,ug/ml of MC or 0.5 ,g/ml of erythromycin. No mitomycin-resistant transformants were detected during the first 90 min; the maximal number of potential transformants was expressed after 210 min (Fig. 2) . In the same experiment, the expression of tryptophan independence and erythromycin resistance occurred at the earliest time examined (10 min after deoxyribonuclease) and was maximal in 20 to 30 min. The division lag observed for the transformants can be attributed to the latency phenomenon described by Nester and Stocker (14, 15 with decreasing DNA concentration. Since the mac-i mutation [referred to as ery-r by Takahashi (22) ] was localized in an early-replicating region of the B. subtilis chromosome (22) , this indicated that the three mit mutations were clustered, linked to mac-i, and chromosomally located in this repplicating segment.
Transfer from multistep mutants of levels of resistance characteristic ofearlier mutational steps. The multistep mutants, mit-2-01 and mit-2-01-01, were derived in two successive mutational steps from the strain bearing the primary mutation mit-2. The resistance of these two derivatives is illustrated, along with that of mit-2 and the strain bearing none of these mutations (MC-sensitive), in Fig. 1 . The rationale for designating the strains in the above manner was derived from transformation experiments in which it was found that each of the three levels of resistance and only these three levels could be transferred by DNA extracted from mutant mit-2-01-00. By contrast, DNA from a strain bearing mit-2-01 could disseminate two levels of resistance and DNA from mit-2 a single level of resistance (Table 3 and Fig.  4 ). The levels of resistance disseminated by recombination thus reflect accurately the levels of resistance that were acquired by spontaneous mutation. Transformants with resistance lower than or intermediate within these three levels were not encountered. Furthermore, all transformants were selected as a rule on media containing the minimal permissible concentration of the antibiotic. It was therefore tentatively concluded that the secondary mutations, mit-01 and mit-O01-00, did not by themselves, singly or in combination, confer any resistance per se. They appeared merely to enhance the resistance of the primary mutation, mit-2, from which they were derived. However, and although unlikely, the possibility that these secondary mutations had a resistance identical to that conferred by mit-2 cannot at the present time be excluded. A definitive resolution of this question has been rendered difficult because the strain bearing mit-2 is a poor recipient in transformation reactions. -Resistance levels determined by replication in the first instance; in each experiment, one colony representative of each repicating class was regrown in Penassay Broth and the resistance was confirmed by re-examination in a more detailed manner (Fig. 4) . Linkage between sites determiningfirst-, second-, and third-step resistance. Results from experiments with concentrations of DNA below saturating levels (Table 3) suggested linkage between the primary mutation mit-2 and the subsequently acquired mutations. This was, however, examined more critically by determining the frequency of transformation to each level of resistance as a function of concentration of transforming DNA (Fig. 5) . In this experiment, the sensitive strain was exposed for 30 min to three different concentrations of DNA extracted from the triple-step mutant mit-2-O1-O01. Transformants were selected on NA containing 0.15 jig/ml of MC transferred to NA, and tested for the degree of resistance they had acquired by velvet replication on a series of NA plates containing increasing concentrations of the antibiotic. Since the fraction of transformants with "multistep levels" of resistance was independent of the concentration of DNA over a linear response region, this finding established the association of all three sites in one transforming fragment of DNA. (11) that the mitomycins are reduced in vivo before they can exert their action. The relative unavailability of a reducing system in resistant mutants could provide a plausible mechanism for securing resistance specifically to the mitomycin family of antibiotics. It is possible that such mutations may be encountered. If they do occur, it is not necessary to expect them to be cross-resistant to agents that function independently of a reducing system. However, an examination of several MC-resistant mutants of E. coli by Greenberg et al. (9) indicated that these mutants are cross-resistant to a variety of agents, including those that apparently do not have to be reduced before they are functional. Preliminary observations in this laboratory on B. subtilis mutants also indicate such patterns of cross-resistance. The early-replicating segment of the B. subtilis chromosome bears genetic loci for ribosomal and soluble ribonucleic acid species (16, 17) , adenine requirement (16, 26) , and resistance to streptomycin and erythromycin (8) . In E. coli, streptomycin 
